Intravenous beta-blockers in ST-segment elevation myocardial infarction: A systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference28 articles.
1. Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance;Bonanad;Eur. J. Radiol.,2016
2. Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trial;Dokainish;Echocardiography,2014
3. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines;O'Gara;J. Am. Coll. Cardiol.,2013
4. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of β-blockers in the cardiovascular disease continuum: a collaborative Delphi survey-based consensus from Asia-Pacific;Current Medical Research and Opinion;2023-09-25
2. 2023 ESC Guidelines for the management of acute coronary syndromes;European Heart Journal: Acute Cardiovascular Care;2023-09-22
3. Heart rate and heart rate variability as a prognosticating feature for functional outcome after cardiac arrest: A scoping review;Resuscitation Plus;2023-09
4. 2023 ESC Guidelines for the management of acute coronary syndromes;European Heart Journal;2023-08-25
5. Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials;Cardiovascular Drugs and Therapy;2023-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3